What is Tatva Chintan Pharma Chem Enterprise Value?
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Tatva Chintan Pharma Chem's Enterprise Value is ₹20,162 Mil.
Tatva Chintan Pharma Chem's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was ₹254 Mil. Therefore, Tatva Chintan Pharma Chem's EV-to-EBIT ratio for today is 79.32.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Tatva Chintan Pharma Chem's Enterprise Value
For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tatva Chintan Pharma Chem's Enterprise Value Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Tatva Chintan Pharma Chem's Enterprise Value falls into.
Tatva Chintan Pharma Chem Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Tatva Chintan Pharma Chem's Enterprise Value for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tatva Chintan Pharma Chem (NSE:TATVA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Tatva Chintan Pharma Chem's EV-to-EBIT for today is
Tatva Chintan Pharma Chem's current Enterprise Value is ₹20,162 Mil.
Tatva Chintan Pharma Chem's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹254 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Tatva Chintan Pharma Chem's EV-to-EBITDA for today is:
Tatva Chintan Pharma Chem's current Enterprise Value is ₹20,162 Mil.
Tatva Chintan Pharma Chem's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹517 Mil.
Tatva Chintan Pharma Chem's current Enterprise Value is ₹20,162 Mil.
Tatva Chintan Pharma Chem's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,684 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tatva Chintan Pharma Chem Enterprise Value Related Terms
Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:TATVA has been successfully added to your 